EQS-News: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
|
EQS-News: SARTORIUS AG
/ Key word(s): Dividend
Göttingen, Germany | February 6, 2026
The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share At today’s meeting, the Supervisory Board of Sartorius AG approved the Executive Board’s recommendation to submit a proposal to the Annual General Meeting on March 26, 2026, to pay a dividend of 0.74 euros per preference share and 0.73 euros per ordinary share for fiscal 2025, the same amount as in 2024. The total distributed profit would accordingly be 50.8 million euros. The dividend will be paid on March 31, 2026. This media release contains forward-looking statements about the future development of the Sartorius Group. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Sartorius assumes no liability for updating such statements in light of new information or future events. Financial calendar February 16, 2026 | Publication of the 2025 Annual Report March 26, 2026 | Annual General Meeting April 23, 2026 | Publication of the first quarter results for January to March 2026 July 23, 2026 | Publication of half-year results for January to June 2026 October 22, 2026 | Publication of nine-month results for January to September 2026 A profile of Sartorius Sartorius is a leading international partner to the biopharmaceutical research and manufacturing industries. The Lab Products & Services Division focuses on innovative laboratory instruments and consumables for research and quality assurance laboratories in pharmaceutical and biopharmaceutical companies as well as academic research institutions. The Bioprocess Solutions Division supports customers with a broad product portfolio focused on single-use solutions for the safer, faster, and more sustainable production of biotech drugs, vaccines, and cell and gene therapies. With around 60 production and sales locations worldwide, the Göttingen-based company has a strong global presence. Sartorius regularly supplements its portfolio with acquisitions of complementary technologies. In 2025, according to preliminary figures, the company generated sales revenue of around 3.5 billion euros. More than 14,000 employees serve customers around the globe. Visit our newsroom and follow us on LinkedIn. Contact Verena Sattel External Communications +49 551 308 9261 verena.sattel@sartorius.com Additional features: File: The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share | Media Release
06.02.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | SARTORIUS AG |
| Otto-Brenner-Straße 20 | |
| 37079 Göttingen | |
| Germany | |
| Phone: | +49.(0)551-308.0 |
| Fax: | +49.(0)551-308.3289 |
| E-mail: | info@sartorius.com |
| Internet: | www.sartorius.com |
| ISIN: | DE0007165631, DE0007165607 |
| WKN: | 716563, 716560 |
| Indices: | MDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Hanover; Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2272694 |
| End of News | EQS News Service |
|
|
2272694 06.02.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | ||
| Sales1 | 2.335,66 | 3.449,22 | 4.174,70 | 3.395,70 | 3.380,70 | 3.538,10 | 3.805,00 | |
| EBITDA1,2 | 636,70 | 1.134,26 | 1.410,40 | 962,70 | 945,30 | 1.051,60 | 1.165,00 | |
| EBITDA-Margin3 | 27,26 | 32,89 | 33,78 | 28,35 | 27,96 | 29,72 | 30,62 | |
| EBIT1,4 | 456,11 | 903,16 | 1.064,80 | 503,90 | 530,00 | 542,60 | 565,00 | |
| EBIT-Margin5 | 19,53 | 26,18 | 25,51 | 14,84 | 15,68 | 15,34 | 14,85 | |
| Net Profit (Loss)1 | 299,56 | 426,98 | 913,10 | 290,60 | 137,40 | 230,40 | 250,00 | |
| Net-Margin6 | 12,83 | 12,38 | 21,87 | 8,56 | 4,06 | 6,51 | 6,57 | |
| Cashflow1,7 | 511,53 | 865,81 | 734,20 | 853,60 | 976,00 | 837,00 | 860,00 | |
| Earnings per share8 | 4,38 | 8,09 | 9,58 | 4,95 | 5,30 | 4,79 | 5,30 | |
| Dividend per share8 | 0,71 | 1,26 | 1,44 | 0,74 | 0,74 | 0,74 | 1,44 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Sartorius VZ | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 716563 | DE0007165631 | AG | 15.095,81 Mio € | 10.07.1990 | Halten | 9F3FHV2Q+JW |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 37,60 | 40,40 | 0,93 | 51,87 | 6,36 | 20,18 | 4,27 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,74 | 0,74 | 0,74 | 0,34% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 26.03.2026 | 23.04.2026 | 23.07.2026 | 22.10.2026 | 16.02.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -6,12% | +1,67% | -10,88% | -10,01% | +3.656,18% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
